C12N 2710/10323
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2710/10323 (Virus like particles [vlp]) appears on 10 US grants and 17 published applications in this corpus.
Search patents in C12N- Granted patents
- 10
- Published applications
- 17
- Assignees
- 16
- Inventors
- 57
- Latest grant
- 22 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 0 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 2 |
| 2022 | 1 | 3 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Adenoviral coat protein derived delivery vehicles22 Oct 2024US 12,122,806 B2Centre National de la Recherche Scientifique (CNRS)
- Adenoviral coat protein derived delivery vehicles15 Mar 2022US 11,274,127 B2Centre National de la Recherche Scientifique (CNRS)
- Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof24 Aug 2021US 11,098,324 B2Nouscom AG
- Cell-free methods of producing vault particles and vault particles resulting therefrom21 Jan 2020US 10,537,529 B2The Regents of the University of California
- Adenoviral vector-based vaccine against enterovirus infection26 Jun 2018US 10,004,796 B2National Health Research Institutes
- Recombinant virus-like particle capsid vaccines against adenoviruses and compositions, methods, and use thereof19 Jun 2025US 2025/0197885 A1TechnoVax, Inc.
- Gorilla adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof4 Jan 2024US 2024/0002879 A1
- Engineered Polypeptides Derived From Variable Domain of Adenovirus Penton Base30 Mar 2023US 2023/0101439 A1Imophoron Limited
- Agent for inducing specific immunity against severe acute respiratory syndrome virus sars-cov-2 in liquid form (variants)18 Aug 2022US 2022/0259618 A1
- Adenoviral coat protein derived delivery vehicles26 May 2022US 2022/0162267 A1Centre National de la Recherche Scientifique (CNRS)
Most cited
By later US patents
- Adenovirus with modified binding moiety specific for the target cells150US 5,885,808 AImperial Cancer Research Technology, Ltd. · 1999
- Adenovirus for delivering foreign DNA into higher eukaryotic cells67US 5,693,509 ABoehringer Ingelheim International GmbH · 1997
- Targeted delivery through a cationic amino acid transporter8US 6,498,027 B1Introgene B.V. · 2002
- Adenovirus dodecahedron particles for delivery of pharmaceutical agents4US 8,765,666 B2Instytut Bio Chemii I Biofizki Pan · 2014